These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17414576

  • 1. Drospirenone, a progestin with added value for hypertensive postmenopausal women.
    Archer DF.
    Menopause; 2007; 14(3 Pt 1):352-4. PubMed ID: 17414576
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH.
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
    White WB, Pitt B, Preston RA, Hanes V.
    Circulation; 2005 Sep 27; 112(13):1979-84. PubMed ID: 16186434
    [Abstract] [Full Text] [Related]

  • 4. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct 27; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
    Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V.
    Am J Hypertens; 2005 Jun 27; 18(6):797-804. PubMed ID: 15925739
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH, Hanes V, Alonso A, Ni P, Poola N, Silang R, Blode H, Preston RA.
    J Clin Pharmacol; 2007 Oct 27; 47(10):1292-302. PubMed ID: 17906162
    [Abstract] [Full Text] [Related]

  • 8. Clinical application of antialdosterone-containing hormone therapy for postmenopausal women.
    Minkin MJ.
    J Reprod Med; 2007 Feb 27; 52(2 Suppl):165-8. PubMed ID: 17477111
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Added benefits of drospirenone for compliance.
    Foidart JM.
    Climacteric; 2005 Oct 27; 8 Suppl 3():28-34. PubMed ID: 16203653
    [Abstract] [Full Text] [Related]

  • 11. Estradiol + drospirenone.
    Prescrire Int; 2007 Jun 27; 16(89):106. PubMed ID: 17590905
    [Abstract] [Full Text] [Related]

  • 12. Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
    Ylikorkala O.
    Climacteric; 2005 Oct 27; 8 Suppl 3():1-3. PubMed ID: 16203649
    [No Abstract] [Full Text] [Related]

  • 13. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris.
    Knuuti J, Kalliokoski R, Janatuinen T, Hannukainen J, Kalliokoski KK, Koskenvuo J, Lundt S.
    Am J Cardiol; 2007 Jun 15; 99(12):1648-52. PubMed ID: 17560868
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
    White WB, Hanes V, Chauhan V, Pitt B.
    Hypertension; 2006 Aug 15; 48(2):246-53. PubMed ID: 16801478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
    Archer DF.
    J Reprod Med; 2007 Feb 15; 52(2 Suppl):159-64. PubMed ID: 17477110
    [Abstract] [Full Text] [Related]

  • 18. Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.
    Preston RA.
    Climacteric; 2007 Feb 15; 10 Suppl 1():32-41. PubMed ID: 17364596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
    Vitale C, Mammi C, Gambacciani M, Russo N, Spoletini I, Fini M, Volterrani M, Rosano GMC.
    Int J Cardiol; 2017 Jan 15; 227():217-221. PubMed ID: 27843051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.